Objective: To compare effects of Atorvastatin (40mg/80mg) and 0.1% Betamethasone Valerate on progress of psoriasis with cardiovascular complications.
Methodology: This study was comparative interventional randomized clinical trial conducted in Pharmacology Department of Basic Medical Sciences Institute, Jinnah Postgraduate Medical Center (JPMC), with the collaboration of Dermatology department of JPMC, Karachi. The study period was from June 2013 to June 2016. A total of 225 patients were divided into group A, B and C. Post treatment effects of drugs were evaluated by different parameters (Psoriasis Area and Severity Index (PASI), High Sensitivity C-Reactive Protein (hsCRP), Lipid profile, Liver Function Test (LFT) Creatine Phosphokinase (CPK)). The quality of life was evaluated in those patients by Dermatological Life Quality Index(DLQI).
Results: The mean percentage change of PASI and hsCRP showed highly significant changes at twelve and twenty weeks. Before and after the treatment mean Lipid profile and DLQI also showed significant changed. LFT and adverse event had non-significant change at the end of treatment.
Conclusion: Atorvastatin had remarkable results on psoriasis disease severity and cardiovascular complication were same as standard therapy 0.1% Betamethasone Valerate. When the combination of drugs was used, more significant results were seen as compared to single therapy.
Atorvastatin, 0.1% Betamethasone Valerate, Psoriasis Severity and Cardiovascular complication.
Passive social media use and psychological well-being during the COVID-19 pandemic: The role of social comparison and emotion regulation.
Yue Z, Zhang R, Xiao J
Computers in human behavior. 2022; 127(): 107050
Biovalue in Human Brain Banking: Applications and Challenges for Research in Neurodegenerative Diseases.
Methods in molecular biology (Clifton, N.J.). 2022; 2389(): 209-220
Using the Health Belief Model to examine travelers' willingness to vaccinate and support for vaccination requirements prior to travel.
Suess C, Maddock J, Dogru T, Mody M, Lee S
Tourism management. 2022; 88(): 104405
Occupant health in buildings: Impact of the COVID-19 pandemic on the opinions of building professionals and implications on research.
Awada M, Becerik-Gerber B, White E, Hoque S, O'Neill Z, Pedrielli G, Wen J, Wu T
Building and environment. 2022; 207(): 108440
Exploring the Alzheimer's disease neuroepigenome: recent advances and future trends.
Zhang H, Elefant F
Neural regeneration research. 2022; 17(2): 325-327